These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 2696951

  • 1. Vascular architecture of melanocytic skin tumors. A quantitative immunohistochemical study using automated image analysis.
    Smolle J, Soyer HP, Hofmann-Wellenhof R, Smolle-Juettner FM, Kerl H.
    Pathol Res Pract; 1989 Nov; 185(5):740-5. PubMed ID: 2696951
    [Abstract] [Full Text] [Related]

  • 2. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
    Barnhill RL, Fandrey K, Levy MA, Mihm MC, Hyman B.
    Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
    [Abstract] [Full Text] [Related]

  • 3. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG.
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.
    Rudolph P, Lappe T, Schubert C, Schmidt D, Parwaresch RM, Christophers E.
    Am J Pathol; 1995 Dec; 147(6):1615-25. PubMed ID: 7495287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E, Mack AF, Garbe C, Klessen C.
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
    Yasuda H.
    Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z, Lind AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH, Wick MR.
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [Abstract] [Full Text] [Related]

  • 13. Increased laser Doppler flow in skin tumors corresponds to elevated vessel density and reactive hyperemia.
    Stücker M, Springer C, Paech V, Hermes N, Hoffmann M, Altmeyer P.
    Skin Res Technol; 2006 Feb; 12(1):1-6. PubMed ID: 16420531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H, Günzel S, Schäffer U, Tanner B, Heine M.
    Cancer; 2000 Mar 15; 88(6):1370-7. PubMed ID: 10717619
    [Abstract] [Full Text] [Related]

  • 16. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
    Smolle J, Soyer HP, Juettner FM, Hoedl S, Kerl H.
    Pathol Res Pract; 1988 Jun 15; 183(3):266-70. PubMed ID: 3420029
    [Abstract] [Full Text] [Related]

  • 17. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study.
    Rieger E, Hofmann-Wellenhof R, Soyer HP, Kofler R, Cerroni L, Smolle J, Kerl H.
    J Cutan Pathol; 1993 Jun 15; 20(3):229-36. PubMed ID: 8103531
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
    Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG.
    Eur J Dermatol; 2011 Jun 15; 21(1):18-21. PubMed ID: 21262599
    [Abstract] [Full Text] [Related]

  • 19. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M.
    Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.